Citius Oncology (CTOR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Oct7

Citius Oncology Establishes International Access for LYMPHIR™ in Southern Europe

12:48

Aug13

Citius Oncology released FY2025 9 Months Earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.2762

03:00

Citius Oncology released FY2025 Q3 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0799 (forecast USD -0.15)

03:00

Jul17

Citius Oncology Completes $9 Million Public Offering

22:35

Jul15

Citius Oncology Signs Distribution Agreement to Enhance LYMPHIR Commercial Infrastructure

12:35

Jul14

Citius Oncology Announces Equity Offering Plan, Stock Price Dropped

14:59

Schedules & Filings

Schedules

Filings

Aug12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.37 M, EPS -0.075

May14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.736 M, EPS -0.1081

Feb14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.659 M, EPS -0.093

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change